Citi raises Arcus Biosciences price target to $50
Tweet Send to a Friend
Citi analyst Yigal Nochomovitz raised his price target on Arcus Biosciences (NYSE: RCUS) to $50 from $45, while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE




